SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-018245
Filing Date
2022-05-05
Accepted
2022-05-05 16:09:09
Documents
99
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mnkd-10q_20220331.htm   iXBRL 10-Q 2791315
2 EX-10.1 mnkd-ex101_339.htm EX-10.1 44052
3 EX-31.1 mnkd-ex311_10.htm EX-31.1 17419
4 EX-31.2 mnkd-ex312_11.htm EX-31.2 17397
5 EX-32.1 mnkd-ex321_8.htm EX-32.1 7310
6 EX-32.2 mnkd-ex322_7.htm EX-32.2 7301
  Complete submission text file 0001564590-22-018245.txt   12089114

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20220331.xsd EX-101.SCH 99911
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnkd-20220331_cal.xml EX-101.CAL 72490
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnkd-20220331_def.xml EX-101.DEF 395119
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20220331_lab.xml EX-101.LAB 621625
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20220331_pre.xml EX-101.PRE 573510
93 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-10q_20220331_htm.xml XML 2305121
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 22896288
SIC: 2834 Pharmaceutical Preparations